Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
4.620
-0.160 (-3.35%)
At close: Dec 5, 2025, 4:00 PM EST
4.630
+0.010 (0.21%)
After-hours: Dec 5, 2025, 7:57 PM EST
Achieve Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 25.92 | 16.25 | 11.44 | 10.72 | 9.13 | 7.87 | |
| Research & Development | 26.42 | 22.82 | 15.81 | 30.08 | 23.97 | 6.88 | |
| Operating Expenses | 52.34 | 39.07 | 27.25 | 40.8 | 33.09 | 14.75 | |
| Operating Income | -52.34 | -39.07 | -27.25 | -40.8 | -33.09 | -14.75 | |
| Interest Expense | -0.77 | -2.18 | -2.85 | -1.79 | - | - | |
| Interest & Investment Income | 1.55 | 2.36 | 0.83 | 0.2 | 0.02 | 0.07 | |
| Other Non Operating Income (Expenses) | -0.05 | -0.03 | -0.01 | 0.04 | -0.08 | -0.05 | |
| EBT Excluding Unusual Items | -51.6 | -38.92 | -29.29 | -42.35 | -33.15 | -14.73 | |
| Other Unusual Items | -0.74 | -0.9 | -0.53 | - | - | - | |
| Pretax Income | -52.35 | -39.83 | -29.82 | -42.35 | -33.15 | -14.73 | |
| Net Income | -52.35 | -39.83 | -29.82 | -42.35 | -33.15 | -14.73 | |
| Net Income to Common | -52.35 | -39.83 | -29.82 | -42.35 | -33.15 | -14.73 | |
| Shares Outstanding (Basic) | 39 | 32 | 20 | 11 | 8 | 3 | |
| Shares Outstanding (Diluted) | 39 | 32 | 20 | 11 | 8 | 3 | |
| Shares Change (YoY) | 34.94% | 61.75% | 87.17% | 30.46% | 198.64% | 559.42% | |
| EPS (Basic) | -1.35 | -1.24 | -1.50 | -4.00 | -4.08 | -5.42 | |
| EPS (Diluted) | -1.35 | -1.24 | -1.50 | -4.00 | -4.08 | -5.42 | |
| Free Cash Flow | -40.68 | -29.77 | -24.5 | -37.57 | -29.44 | -13.49 | |
| Free Cash Flow Per Share | -1.05 | -0.93 | -1.24 | -3.55 | -3.63 | -4.96 | |
| EBITDA | -52.11 | -38.84 | -27.02 | -40.56 | -32.84 | -14.5 | |
| D&A For EBITDA | 0.23 | 0.23 | 0.23 | 0.24 | 0.25 | 0.26 | |
| EBIT | -52.34 | -39.07 | -27.25 | -40.8 | -33.09 | -14.75 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.